BioStock: Arcede Pharma’s CEO is ready for Spotlight

Report this content

When BioStock contacts Arcede Pharma’s new CEO Mia Lundblad, the company is just about to be listed for trading on Spotlight Stock Market. We spoke to Mia to find out more about her background; the journey from Astra Hässle, via Novo Nordisk, to a small development company in Lund with ambitions to launch the next generation COPD treatment.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/06/arcede-pharmas-ceo-is-ready-for-spotlight/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Subscribe

Documents & Links

Quick facts

BioStock: Arcede Pharma’s CEO is ready for Spotlight
Tweet this